Autumn updates: What’s ahead for CERTAINTY

As the year enters its final stretch, the CERTAINTY consortium is fully focused on delivering key activities that will shape the next phase of the project. While October has been a quieter month externally, work has continued at full pace behind the scenes.

Preparing for Our Second Stakeholder Workshop

In November, CERTAINTY will host its Second Stakeholder Workshop, bringing together patients, clinicians, regulatory experts, and project partners to review the first prototype of the Virtual Twin for CAR T cell therapy in multiple myeloma.

Throughout October, the team has been actively refining the agenda, finalising content, and coordinating stakeholder contributions to ensure meaningful exchange and feedback.

Project Progress and Planning

The consortium is currently working intensively on several key deliverables and milestones due this autumn. These outputs will help consolidate progress made in the last year and set the direction for 2026.

Looking Ahead: CERTAINTY Annual Meeting 2026

Preparations have also begun for the CERTAINTY Annual Meeting 2026, which will bring together all project partners to review progress, align on next steps, and plan for the year ahead.

Coming Soon: CERTAINTY Hackathon

Planning is underway for the first CERTAINTY Hackathon, expected to take place in early 2026. The event will provide a collaborative environment for developers, researchers, and clinicians to interact with and challenge elements of the Virtual Twin prototype.

Advancing Together

This phase of the project highlights the strength of CERTAINTY’s cross-disciplinary collaboration, uniting clinical, technical, legal, and patient perspectives to co-create a decision-support tool grounded in real-world needs.